G Stingl
Impact in
- Dermatology top 0.2%
- Dermatology and Skin Diseases
- Cutaneous lymphoproliferative disorders research
- Immunology top 1%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
Papers in
- Dermatology 10
- Dermatology and Skin Diseases 4
- Immunology 15
- Immunotherapy and Immune Responses 7
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 4
- Mast cells and histamine 3
G Stingl
31 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 108
- Dermatology 1.1k
- Immunology 2.0k
- Immunology and Allergy 294
- Pathology and Forensic Medicine 656
- Rheumatology 510
Countries citing papers authored by G Stingl
This map shows the geographic impact of G Stingl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Stingl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Stingl more than expected).
Fields of papers citing papers by G Stingl
This network shows the impact of papers produced by G Stingl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Stingl. The network helps show where G Stingl may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G Stingl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 8 | |
| 2 | 2007 | 32 | |
| 3 | Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) Hit paper breakdown → | 2007 | 559 |
| 4 | 2003 | 1 | |
| 5 | 1998 | 19 | |
| 6 | 1998 | 41 | |
| 7 | 1996 | 269 | |
| 8 | 1996 | 31 | |
| 9 | 1995 | 239 | |
| 10 | 1992 | 113 | |
| 11 | 1991 | 75 | |
| 12 | 1988 | 150 | |
| 13 | Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy Hit paper breakdown → | 1987 | 918 |
| 14 | 1986 | 75 | |
| 15 | 1985 | 23 | |
| 16 | 1983 | 32 | |
| 17 | 1981 | 209 | |
| 18 | 1979 | 162 | |
| 19 | [Kinetoplast of the flagellate crithidia luciliae: a suitable substrate for the detection of antibodies to native, double-stranded DNA in the indirect immuno-fluorescence test (author's transl)]. | 1975 | 1 |
| 20 | 1975 | 95 |
About G Stingl
G Stingl is a scholar working on Dermatology, Immunology, Immunology and Allergy, Pathology and Forensic Medicine and Genetics, having authored 32 papers that have together received 3.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Autoimmune Bullous Skin Diseases (6 papers), T-cell and B-cell Immunology (6 papers), Dermatology and Skin Diseases (4 papers), Urticaria and Related Conditions (4 papers), Immune Cell Function and Interaction (4 papers), Mast cells and histamine (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Dermatology (1.1k citations), Immunology (2.0k citations), Immunology and Allergy (294 citations), Pathology and Forensic Medicine (656 citations) and Rheumatology (510 citations). G Stingl has collaborated with scholars based in Austria, United States and Switzerland. Frequent co-authors include Werner Aberer, A Elbe, Karl Holubar, Klaus Wolff, Klaus Wolff, Louis Dubertret, A. Camez, Kim Papp, J.‐P. Ortonne and Martin Kaul. Their work appears in journals such as The Journal of Immunology, British Journal of Dermatology, Journal of Allergy and Clinical Immunology, Nutrition and Melanoma Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.